Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Paragona is a natural health product (nutraceutical) developed by Professional Botanicals Inc. (also known as Healthy Botanicals Inc.) that was marketed primarily for targeting parasites within the gastrointestinal tract. The product was typically sold in capsule form and was part of a broader line of herbal supplements. In 2018, Health Canada issued a significant safety warning and seized all products manufactured by Professional Botanicals Inc., including Paragona, due to findings that the company was manufacturing products under unsanitary conditions without a valid site license. While marketed as a natural parasite support formula, the specific mechanism of action for its herbal ingredients is generally attributed to the anthelmintic and antimicrobial properties of traditional botanicals often found in such cleanses, such as black walnut, wormwood, and clove, although the exact proprietary blend for this specific brand is not widely detailed in pharmaceutical literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Paragona.